InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Lee Kenneth B Jr. Officer active across 3 companies, notably Eyenovia, INC.. Cumulatively, 9 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €30k. History available since 11 June 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lee Kenneth B Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
16,745 shares0Common StockSEC:0001127602-23-018791:0
15,000 shares@ US$1.7122.4% of flowCommon StockSEC:0001127602-23-003163:0
22,222 shares0Common Stock, par value $.0001SEC:0001415889-22-006807:0
12,866 shares0Common StockSEC:0001127602-22-017144:0
10,000 shares@ US$2.2054.1% of flowCommon Stock, par value $.0001SEC:0001415889-22-005467:0
Canonical exit: 17 Aug 2022 (T+90)
6,963 shares0Common Stock, par value $.0001SEC:0001415889-21-005357:0
15,000 shares@ US$3.2263.4% of flowCommon StockSEC:0001127602-21-025331:0
2,000 shares@ US$5.3829.8% of flowCommon Stock, par value $.0001SEC:0001638599-21-000551:0
Canonical exit: 9 Sept 2021 (T+90)
72,966 sharesCommon SharesSEC:0001104659-16-095182:0
9 of 9 declarations
About Lee Kenneth B Jr
Kenneth B Jr Lee is a director at Eyenovia, INC. and is also associated with Biocryst Pharmaceuticals INC.
